These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27928075)

  • 21. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
    Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.
    Morlock GP; Crawford JT; Butler WR; Brim SE; Sikes D; Mazurek GH; Woodley CL; Cooksey RC
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2291-5. PubMed ID: 10952570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3672-3. PubMed ID: 14576145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.
    Huy NQ; Lucie C; Hoa TTT; Hung NV; Lan NTN; Son NT; Nhung NV; Anh DD; Anne-Laure B; Van Anh NT
    Emerg Microbes Infect; 2017 Oct; 6(10):e86. PubMed ID: 29018250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
    Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
    Ei PW; Mon AS; Htwe MM; Win SM; Aye KT; San LL; Zaw NN; Nyunt WW; Myint Z; Lee JS; Aung WW
    Tuberculosis (Edinb); 2020 Dec; 125():102013. PubMed ID: 33142220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Mestdagh M; Fonteyne PA; Realini L; Rossau R; Jannes G; Mijs W; De Smet KA; Portaels F; Van den Eeckhout E
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2317-9. PubMed ID: 10471589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
    Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH
    BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.
    Chiu YC; Huang SF; Yu KW; Lee YC; Feng JY; Su WJ
    BMC Infect Dis; 2011 Sep; 11():240. PubMed ID: 21910892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.
    Muthaiah M; Jagadeesan S; Ayalusamy N; Sreenivasan M; Prabhu SS; Muthuraj U; Senthilkumar K; Veerappan S
    Int J Mol Sci; 2010 Jul; 11(7):2670-80. PubMed ID: 20717529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    Ngabonziza JCS; Diallo AB; Tagliani E; Diarra B; Kadanga AE; Togo ACG; Thiam A; de Rijk WB; Alagna R; Houeto S; Ba F; Dagnra AY; Ivan E; Affolabi D; Schwoebel V; Trebucq A; de Jong BC; Rigouts L; Daneau G;
    PLoS One; 2017; 12(10):e0187211. PubMed ID: 29088294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
    Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
    Ramirez-Busby SM; Valafar F
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5267-77. PubMed ID: 26077261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
    Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C
    Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
    Hong CY; Wang F; Gui J; Liu XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Mphahlele M; Peters RP; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2015 Dec; 53(12):3779-83. PubMed ID: 26378284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
    Lee KW; Lee JM; Jung KS
    J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.